Menu Back toSession 5: Innovative approaches to integrated evidence

Future of Evidence and Smart Health Conference

Leveraging RWE to advance healthcare decision-making.

Session 5: Innovative approaches to integrated evidence

Session Chair(s)

Adrian Cassidy, PhD, MSc

Adrian Cassidy, PhD, MSc

  • Global Head of RWE and Data Science
  • Novartis, Switzerland
Michael Lees, MA

Michael Lees, MA

  • Chief Operating Officer and Head of Market Access Strategy
  • PHMR Ltd, United Kingdom
Session 5: Innovative Approaches to Integrated Evidence

Speaker(s)

Marcia Rueckbeil

Real world evidence in marketing authorisation applications at EMA

Marcia Rueckbeil

  • Seconded National Expert (Data Analytics and Methods Task Force)
  • European Medicines Agency, Netherlands
Angela Ibald-Mulli, DrPH, MBA, MPH, MS

Integrated Evidence Generation: The Innovation Challenge

Angela Ibald-Mulli, DrPH, MBA, MPH, MS

  • Integrated Evidence Generation Lead Thrombosis
  • Bayer Pharmaceuticals, Germany
Baris Erdogan, PhD

Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcome Research and Non-Research Evaluations

Baris Erdogan, PhD

  • CEO
  • Clinerion Ltd, Switzerland
Ian Rentsch, JD

Accessing Multiple Patient Data Sources to Enhance Generation of Real-World Evidence, Outcome Research and Non-Research Evaluations

Ian Rentsch, JD

  • Chief Gommercial Officer & GM Pharma
  • CENTOGENE GmbH, Germany

Contact us

Trouble connecting on the day of the event?

Send Email
+41 61 225 51 51

Registration Questions?

Send Email
+41 61 225 51 51